Table 2 Univariate and multivariate analyses for overall survival (OS)

Age

    < 65y

29 (64)

33

1

    ≥ 65y

16 (36)

13

1.6 (0.7–3.7)

0.24

Gender

    Male

31 (69)

18

1

    Female

14 (31)

25

1.4 (0.4–2.4)

0.78

ECOG

    0–1

34 (76)

25

1

    ≥ 2

11 (24)

8

1.7 (0.7–4.1)

0.25

IMDC Risk Group

    Favorable

7 (16)

34

1

    Intermediate

36 (80)

18

1.3 (0.3–5.6)

0.70

    Poor

2 (4)

1

1.6 (0.2–13)

0.60

Tumor Histology

    Non-clear Cell

6 (13)

NE

1

    Clear Cell

39 (87)

25

0.8 (0.2–3.8)

0.86

BMI kg/ m ²

    < 25

22 (49)

18

1

    25-29.9

14 (31)

14

1.1 (0.4–2.6 )

0.90

    ≥ 30

9 (20)

24

0.7 (0.2–2.7 )

0.70

Basal Splenic Volume

    < median 280 ml

23 (51)

25

1

    ≥ median 280 ml

22 (49)

18

0.9 (0.4–2.2)

0.94

Splenic Volume (%)

    Not increased

23 (51)

35

1.0

    İncreased

22 (49)

9

2.7 (1.1–6.2)

0.025

2.5 (1–6) 0.048

NLR

    <median 3.40

19 (42)

33

1

    ≥median 3.40

26 (58)

15

2.5 (0.9–6.7)

0.072

2.4 (0.9–6.7) 0.075

PLR

    <median 206

20 (44)

47

1

    ≥median 206

25 (56)

10

2.5 (0.9–6.5)

0.052

2.1 (0.8–5.6) 0.11